LeMaitre Vascular To Present At The Canaccord Genuity Medical Technology & Diagnostics Forum On Thursday, November 14, 2013

BURLINGTON, Mass., Oct. 25, 2013 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) is presenting at the Canaccord Genuity Medical Technology & Diagnostics Forum at the Westin Grand Central in New York, NY, on Thursday, November 14, 2013. George W. LeMaitre, Chairman & CEO, will provide an update on the Company at 3:00 pm EST.

About LeMaitre Vascular

LeMaitre Vascular is a provider of devices and implants for the treatment of peripheral vascular disease, a condition that affects more than 20 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. The Company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. Additional information can be found at http://www.lemaitre.com .

LeMaitre and the LeMaitre Vascular logo are registered trademarks of LeMaitre Vascular, Inc.
CONTACT: LeMaitre Vascular, Inc.         Mary Nielson         +1-781-425-1659         mnielson@lemaitre.com         http://www.lemaitre.com

LeMaitre Vascular, Inc. Logo

If you liked this article you might like

5 Small-Caps That Could Be Big Performers

4 Blue-Chip Health-Care Picks on Sale (and the Portfolio Is Up 163% Since 2006)

Sales Are Flowing for Small-Cap Biotech

Jim Cramer's 'Mad Money' Recap: Here's What's Important Next Week

Insider Trading Alert - HIL, PCRX And LMAT Traded By Insiders